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期間 C１０．５％，菌量２＋で期間 A１２．５％，期間 B
０．０％，期間 C５０．０％，菌量３＋で期間 A６０．０％，




Fig. 3 月別便中MRSA検出患者数（入院）と VCM内
服薬使用患者数















































Table 4 培養による保菌推定結果と ICTの保菌調査の比較Table 2 各期間の菌量別 VCM内服薬使用率（％）
Table 3 新規患者の ICTの保菌調査結果と VCM内服
薬使用状況

















































































The product of the report to use Vancomycin（VCM）
internal medicine properly and its result
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Methichillin-resistant Staphylococcus aureus（MRSA）carrier investigation began as a part of
Infection Control Team（ICT）activities in Matsuyama Red Cross Hospital in August,２００７. It was
proved that MRSA carrier patient had many medication examples of VCM internal medicine. It
was changed by putting MRSA carrier comments on the report of the convenience cultivation
after May,２００８as an improvement. It was less difficult to use VCM internal medicine properly.
A subject was made of１４９ inpatients who detected MRSA between January２００７ through July
２００９by the convenience cultivation. It was divided into four periods（The period before MRSA
carrier investigation starts, during MRSA carrier investigation, a period before the report change
and a period after the report change）. A MRSA detection patient, the activity ratio of the VCM
internal medicine, the amount of use, and conditions of use were investigated as well, along with
our activities. As for the amount of use of the VCM internal medicine, it was compared with
before the beginning of MRSA carrier investigation and MRSA carrier investigation before the
report change, and obviously it decreased after the report change. A big cost reduction was
attained. On the examination of the VCM internal medicine use conditions, there was no
relationship to the amount of fungus of the MRSA and the result of MRSA carrier investigation,
and there was use example on period before the report. But, MRSA carrier patients didn’t have
a use example in the period after the report change. Therefore, we could think about how the
preparation of the report with MRSA carrier estimated comment added it contributed to the
correct use of VCM. A useless cost could then be reduced.
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